Drug information for SEROSTIM

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; INJECTION 4MG/VIAL Prescription BX  SOMATROPIN RECOMBINANT Human Growth Hormone EMD SERONO 20604
2012-04-06 Label
2012-04-05 Letter
2011-02-15 Review
2009-11-19 Letter
2009-09-16 Review
2009-09-16 Review
2007-09-04 Letter
2007-09-04 Label
2007-08-30 Letter
2007-08-30 Label
2007-08-06 Review
2007-07-24 Letter
2007-07-16 Label
2006-12-04 Label
2006-12-04 Letter
2006-09-25 Letter
2006-09-25 Label
2005-08-31 Label
2005-08-31 Letter
2005-02-17 Label
2005-02-17 Letter
2004-07-14 Label
2004-07-14 Letter
2003-12-08 Label
2003-12-04 Letter
2003-09-09 Letter
2003-09-09 Label
INJECTABLE; INJECTION 5MG/VIAL Prescription BX  SOMATROPIN RECOMBINANT Human Growth Hormone EMD SERONO   "
INJECTABLE; INJECTION 6MG/VIAL Prescription BX  SOMATROPIN RECOMBINANT Human Growth Hormone EMD SERONO   "
INJECTABLE; INJECTION 8.8MG/VIAL Discontinued   SOMATROPIN RECOMBINANT Human Growth Hormone EMD SERONO   "

Drug Adverse Effects information for SEROSTIM

Role code Indications Reaction # Reports
PS ANTIRETROVIRAL THERAPY DEVICE RELATED INFECTION 5
PS ANTIRETROVIRAL THERAPY NEPHROLITHIASIS 5
PS CACHEXIA DEATH 1
PS CACHEXIA MACULAR HOLE 1
PS HIV INFECTION NASOPHARYNGITIS 5
PS HIV WASTING SYNDROME CHOLECYSTITIS 1
PS HIV WASTING SYNDROME CHOLELITHIASIS 1
PS HIV WASTING SYNDROME DEMENTIA 1
PS HIV WASTING SYNDROME EYE SWELLING 1
PS HIV WASTING SYNDROME NASOPHARYNGITIS 1
PS HIV WASTING SYNDROME OXYGEN SATURATION DECREASED 1
PS HIV WASTING SYNDROME PANCREATITIS 2
PS LENTIVIRUS TEST POSITIVE DEVICE RELATED INFECTION 1
PS LENTIVIRUS TEST POSITIVE NEPHROLITHIASIS 1
SS HIV WASTING SYNDROME CHOLECYSTITIS 2
SS HIV WASTING SYNDROME CHOLELITHIASIS 2
SS HIV WASTING SYNDROME EYE SWELLING 2
SS HIV WASTING SYNDROME PANCREATITIS 2
C LIPODYSTROPHY ACQUIRED MYOCARDIAL INFARCTION 1
Ads by Google